Christoph Röllig

16.5k citations

143 papers · 3.4k indexed · 1 hit paper · h-index 30

Hematology top 0.2%
- Acute Myeloid Leukemia Research 87
- Multiple Myeloma Research and Treatments 34
- Hematopoietic Stem Cell Transplantation 22
- Chronic Myeloid Leukemia Treatments 21
Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19
- Chronic Lymphocytic Leukemia Research 14
Oncology top 5%
Immunology top 5%
Public Health, Environmental and Occupational Health top 5%
- Acute Lymphoblastic Leukemia research 22
Molecular Biology
- Retinoids in leukemia and cellular processes 11

Co-authors: Martin Bornhäuser Gerhard Ehninger Stefan Knop Christian Thiede Michael Krämer Uwe Platzbecker Johannes Schetelig Markus Schaich
Cited by: Hematology Genetics Oncology
Partner nations: Germany United States Spain

In The Last Decade

Christoph Röllig

136 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Christoph Röllig

Since Specialization

Citations

This map shows the geographic impact of Christoph Röllig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Röllig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Röllig more than expected).

Fields of papers citing papers by Christoph Röllig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Röllig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Röllig. The network helps show where Christoph Röllig may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christoph Röllig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christoph Röllig Line = papers co-authored together Christoph Röllig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia Jan‐Niklas Eckardt,Ishan Srivastava,Freya Schulze,Susann Winter,Tim Schmittmann,Sebastian Riechert,Martin Schneider,Lukas Reichel,Miriam Eva Helena Gediga,Katja Sockel,Anas Shekh Sulaiman,Christoph Röllig,Frank Kroschinsky,Anne-Marie Asemissen,Christian Pohlkamp,Torsten Haferlach,Martin Bornhäuser,Karsten Wendt,Jan Moritz Middeke	2025	0
2	The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML Sebastian Stasik,Jan‐Niklas Eckardt,Christoph Röllig,Claudia D. Baldus,Uwe Platzbecker,Hubert Serve,Carsten Müller‐Tidow,Kerstin Schäfer‐Eckart,Martin Kaufmann,Stefan W. Krause,Tim Sauer,Mathias Hänel,Andreas Neubauer,Gerhard Ehninger,Martin Bornhäuser,Johannes Schetelig,Jan Moritz Middeke,Christian Thiede,(unknown)	2025	0
3	Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study Christoph Röllig,Christoph Schliemann,Leo Ruhnke,Lars Fransecky,Björn‐Niklas Heydrich,Maher Hanoun,Richard Noppeney,Kerstin Schäfer‐Eckart,Knut Wendelin,Jan‐Henrik Mikesch,Jan Moritz Middeke,Manja Reimann,Frank Fiebig,Sven Zukunft,Martin Wermke,Hubert Serve,Uwe Platzbecker,Carsten Müller‐Tidow,Claudia D. Baldus,Martin Bornhäuser	2024	3
4	Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML Julia M. Unglaub,Richard F. Schlenk,Jan Moritz Middeke,Stefan W. Krause,Sabrina Kraus,Hermann Einsele,Michael Krämer,Sven Zukunft,Joseph Kauer,Simon Renders,Elena Katelari,Christoph Schliemann,Caroline Pabst,Thomas Luft,Peter Dreger,Christoph Röllig,Martin Bornhäuser,Carsten Müller‐Tidow,Tim Sauer	2024	1
5	PHASE 1 STUDY OF PRT1419 (MCL1 INHIBITOR) AS MONOTHERAPY OR IN COMBINATION WITH AZACITIDINE OR VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MYELOID OR B‐CELL MALIGNANCIES R. R. Zuniga,S. Nair,Gina Keiffer,Farhad Ravandi‐Kashani,Aaron D. Goldberg,Elie Traer,Lukas P. Frenzel,Christoph Röllig,Gina Savickas,Wei‐Zen Sun,Sukhreet Atwal,Wan‐Jen Hong,Sarit Assouline	2023	2
6	A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia Brian A. Jonas,Jing‐Zhou Hou,Gail J. Roboz,Caroline Alvares,Deepa Jeyakumar,John Edwards,Harry P. Erba,Richard Kelly,Christoph Röllig,Walter Fiedler,Deanna J. Brackman,Satya R. Siddani,Brenda Chyla,Jacqueline Hilger‐Rolfe,Justin M. Watts	2023	12
7	Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse Katja Sockel,Friedrich Stölzel,Franziska Hönl,Henning Baldauf,Christoph Röllig,Martin Wermke,Malte von Bonin,Raphael Teipel,Cornelia S. Link,Kalina Brandt,Frank Kroschinsky,Mathias Hänel,Anke Morgner,Christian Klesse,Gerhard Ehninger,Uwe Platzbecker,Martin Bornhäuser,Johannes Schetelig,Jan Moritz Middeke	2022	3
8	Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib Alexander E. Perl,Naoko Hosono,Pau Montesinos,Nikolai A. Podoltsev,Giovanni Martinelli,Nicki Panoskaltsis,Christian Récher,Catherine C. Smith,Mark J. Levis,Stephen A. Strickland,Christoph Röllig,Marco Gross‐Langenhoff,Wen‐Chien Chou,Je‐Hwan Lee,Hisayuki Yokoyama,Nahla Hasabou,Qiaoyang Lu,Ramón V. Tiu,Jessica K. Altman	2022	27
9	Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia Maximilian Alexander Röhnert,Michael Krämer,Jonas Schadt,Philipp Ensel,Christian Thiede,Stefan W. Krause,Veit Bücklein,Jörg Hoffmann,Sonia Jaramillo,Richard F. Schlenk,Christoph Röllig,Martin Bornhäuser,Nicholas McCarthy,Sylvie Freeman,Uta Oelschlägel,Malte von Bonin	2022	12
10	Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears Jan‐Niklas Eckardt,Tim Schmittmann,Sebastian Riechert,Michael Krämer,Anas Shekh Sulaiman,Katja Sockel,Frank Kroschinsky,Johannes Schetelig,Lisa Wagenführ,Ulrich S. Schuler,Uwe Platzbecker,Christian Thiede,Friedrich Stölzel,Christoph Röllig,Martin Bornhäuser,Karsten Wendt,Jan Moritz Middeke	2022	41
11	The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia Vladan Vučinić,Leo Ruhnke,Katja Sockel,Maximilian Alexander Röhnert,Donata Backhaus,Dominic Brauer,Georg‐Nikolaus Franke,Dietger Niederwieser,Martin Bornhäuser,Christoph Röllig,Uwe Platzbecker,Sebastian Schwind,Madlen Jentzsch	2021	10
12	Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears Jan‐Niklas Eckardt,Jan Moritz Middeke,Sebastian Riechert,Tim Schmittmann,Anas Shekh Sulaiman,Michael Krämer,Katja Sockel,Frank Kroschinsky,Ulrich S. Schuler,Johannes Schetelig,Christoph Röllig,Christian Thiede,Karsten Wendt,Martin Bornhäuser	2021	60
13	Gemtuzumab Ozogamicin Plus Midostaurin in Combination with Standard Intensive Induction Therapy in Newly Diagnosed AML: Results from a Phase-I Study Christoph Röllig,Christoph Schliemann,Jan‐Henrik Mikesch,Lars Fransecky,Claudia D. Baldus,Björn‐Niklas Heydrich,Maher Hanoun,Richard Noppeney,Sebastian Scholl,Ulf Schnetzke,Kerstin Schäfer‐Eckart,Knut Wendelin,Martin Wermke,Manja Reimann,Frank Fiebig,Theresa Kretschmann,Friedrich Stoelzel,Nael Alakel,Martin Bornhäuser	2021	6
14	Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury Sandra Heuschkel,Theresa Kretschmann,Raphael Teipel,Simone von Bonin,Stephan Richter,Susanne Quick,Nael Alakel,Christoph Röllig,Ekaterina Balaian,Frank Kroschinsky,Holger Knoth,Martin Bornhäuser,Malte von Bonin	2021	6
15	The prevalence of extramedullary acute myeloid leukemia detected by ¹⁸FDG-PET/CT: final results from the prospective PETAML trial Friedrich Stölzel,Tors Lüer,Steffen Löck,Stefani Parmentier,Friederike Kuithan,Michael Krämer,Nael Alakel,Katja Sockel,Franziska Taube,Jan Moritz Middeke,Johannes Schetelig,Christoph Röllig,Tobias Paulus,Jörg Kotzerke,Gerhard Ehninger,Martin Bornhäuser,Markus Schaich,Klaus Zoephel	2019	34
16	The Contribution of a Third Autologous Stem Cell Transplant in the Era of Novel Agents: Favourable Overall Survival and Improvement of Exhausted Bone Marrow Function Susanne Strifler,Inken Hilgendorf,Martina Kleber,Christoph Röllig,Lars‐Olof Mügge,Veronica Teleanu,Sophia Danhof,Martin Schreder,Hermann Einsele,Stefan Knop	2015	1
17	Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia Armin Ehninger,Michael Krämer,Christoph Röllig,Christian Thiede,Martin Bornhäuser,Malte von Bonin,Martin Wermke,Anja Feldmann,Michael Bachmann,Gerhard Ehninger,Uta Oelschlägel,(unknown)	2014	260
18	Multiple myelomabreakdown → Christoph Röllig,Stefan Knop,Martin Bornhäuser	2014	461
19	Mixed response after allogeneic haemopoieticcell transplantation for metastatic renal-cell carcinoma Martin Bornhäuser,Ulrich Klenk,Christoph Röllig,Michael Haack,Jana Babatz,Olaf Koch,Gustavo Baretton,Gerhard Ehninger	2004	2
20	Large-Scale Immunomagnetic Selection of CD14 ⁺ Monocytes to Generate Dendritic Cells for Cancer Immunotherapy: A Phase I Study Jana Babatz,Christoph Röllig,Uta Oelschlägel,Senming Zhao,Gerhard Ehninger,Marc Schmitz,Martin Bornhäuser	2003	48

About Christoph Röllig

Christoph Röllig is a scholar working on Hematology, Genetics and Oncology, having authored 143 papers that have together received 3.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (87 papers), Multiple Myeloma Research and Treatments (34 papers), Hematopoietic Stem Cell Transplantation (22 papers), Acute Lymphoblastic Leukemia research (22 papers), Chronic Myeloid Leukemia Treatments (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Retinoids in leukemia and cellular processes (11 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (595 citations) and Oncology (943 citations). Christoph Röllig has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Martin Bornhäuser, Gerhard Ehninger, Stefan Knop, Christian Thiede, Michael Krämer, Uwe Platzbecker, Johannes Schetelig, Markus Schaich, Brigitte Mohr and Martin Wermke.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact